Bringing a varied selection of health news, medical news, pharma news, research news to you in relation to many aspects within the healthcare, medical healthcare & pharmaceutical landscapes.… Read More #chronicillnessVOICE April 28 health, medical, pharma and research news
Bringing a varied selection of health news, medical news, pharma news, research news to you in relation to many aspects within the healthcare, medical healthcare & pharmaceutical landscapes.… Read More #chronicillnessVOICE April 26 health, medical, pharma and research news
Headlining >>>
FDA’s continuing use of ‘black box’ for antidepressants ignores the harms of this warning | By STEPHEN SOUMERAI AND ROSS KOPPEL
SPONSOR CONTENT BY STAT PLUS
In-depth biopharma, business, and policy analysis at your fingertips… Read More STAT: First Opinion | 2 September 2018
Other talking points from the news
FDA approves landmark drug and controversial app
Monsanto ordered to pay $289 million in Roundup cancer ruling
SPONSOR CONTENT BY PAREXEL | Drug development is too slow and too costly. Four key innovations could help…but they must be widely adopted… Read More STAT: Morning Rounds | Sponsored by Paraxel | 13 August 2018
Top Marketing News
How molecular biomarkers are transforming cancer treatment
AbbVie goes 3-0 in delaying Humira rivals
Drug lobby aims to shake up how medicines are paid for
Where does J&J’s new drug fit in the crowded HIV market?
5 drugs to watch as biotechs report Q2
FDA seeks to make more drugs available over the counter
Gilenya patent decision gives MS market a reprieve… Read More BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up
